Elutia Inc.
General ticker "ELUT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $53.7M (TTM average)
Elutia Inc. does not follow the US Stock Market performance with the rate: -33.5%.
Estimated limits based on current volatility of 5.0%: low 1.10$, high 1.22$
Factors to consider:
- Total employees count: 54 as of 2023
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.45$, 1.55$]
- 2026-12-31 to 2027-12-31 estimated range: [0.55$, 1.68$]
Financial Metrics affecting the ELUT estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -191.71 <= 0.02
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 336.09 > -0.63
- Positive: 42.58 < Shareholder equity ratio, % of 44.38 <= 64.15
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ELUT quotes
Long-term ELUT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $24.75MM | $24.38MM | $12.29MM |
| Operating Expenses | $55.27MM | $60.03MM | $30.70MM |
| Operating Income | $-30.53MM | $-35.65MM | $-18.41MM |
| Non-Operating Income | $-10.70MM | $-18.47MM | $2.55MM |
| Interest Expense | $5.80MM | $4.78MM | $0.39MM |
| R&D Expense | $4.40MM | $3.79MM | $4.16MM |
| Income(Loss) | $-41.22MM | $-54.12MM | $-15.86MM |
| Taxes | $0.03MM | $0.01MM | $0.01MM |
| Other Income(Loss) | $3.59MM | $0.18MM | $0.00MM |
| Profit(Loss)* | $-34.06MM | $-53.77MM | $53.38MM |
| Stockholders Equity | $-38.60MM | $-46.26MM | $27.67MM |
| Inventory | $3.85MM | $3.91MM | $2.62MM |
| Assets | $43.43MM | $36.13MM | $62.35MM |
| Operating Cash Flow | $-21.76MM | $-22.66MM | $-44.81MM |
| Capital expenditure | $0.35MM | $0.65MM | $1.88MM |
| Investing Cash Flow | $14.21MM | $-0.47MM | $78.56MM |
| Financing Cash Flow | $9.84MM | $17.09MM | $-10.64MM |
| Earnings Per Share** | $-1.88 | $-1.85 | $1.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.